Pharmacovigilance and Drug Safety Monitoring

Pharmacovigilance plays a critical role in ensuring the safety and effectiveness of pharmaceutical products throughout their lifecycle, from clinical development to post-marketing surveillance. This session focuses on the latest advancements, strategies, and global practices in drug safety monitoring, highlighting the importance of detecting, assessing, understanding, and preventing adverse drug reactions. With the increasing complexity of drug therapies, including biologics and combination treatments, robust pharmacovigilance systems are essential to identify potential risks and ensure patient safety. The session will explore modern approaches such as real-world evidence, big data analytics, and digital health technologies that are transforming how safety data is collected and analyzed. Signal detection, risk management plans, and benefit-risk assessment methodologies will also be discussed as key components in maintaining drug safety standards. Additionally, global regulatory frameworks and reporting requirements from agencies such as international health authorities will be addressed to provide insights into compliance and best practices. The role of healthcare professionals, patients, and pharmaceutical companies in reporting adverse events and ensuring transparency will be emphasized. Special attention will be given to emerging challenges, including monitoring drug safety in special populations such as pediatrics, geriatrics, and patients with multiple comorbidities. The integration of artificial intelligence and automation in pharmacovigilance systems is further enhancing efficiency, accuracy, and early detection of safety signals. This session aims to provide a comprehensive understanding of current trends and future directions in pharmacovigilance, enabling stakeholders to strengthen drug safety systems and contribute to improved patient outcomes and public health worldwide.

    Related Conference of Pharmacovigilance and Drug Safety Monitoring

    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    June 08-09, 2026

    20th World Drug Delivery Summit

    London, UK
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    July 27-28, 2026

    19th World Drug Delivery Summit

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland

    Pharmacovigilance and Drug Safety Monitoring Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in